Conclusions-There was no therapeutic benefit from the injection of rt-PA into subretinal haemorrhages without concomitant removal in this cat model. (BrJr Ophthalmol 1996;80:658-662) 
nal haemorrhages if evacuated within 7 days. The aim of the study was to determine whether fibrinolysis of subretinal haemorrhage without concomitant removal would offer a simpler approach with similar photoreceptor sparing. Methods-A neodymium YAG laser was used to create experimental subretinal haemorrhages beneath the holangiotic retina of the cat. Tissue plasminogen activator (10 tgIml) was injected into 4 day old subretinal haemorrhages to evaluate its effect on altering the natural history of retinal degeneration. Light and electron microscopy were used to study the histopathological effect. Results-The injection of rt-PA into large 4 day old subretinal haemorrhages without concomitant removal did not alter the natural history of retinal degeneration. In fact, a second focus of retinal degeneration occurred at a gravity dependent inferior site where the subretinal haemorrhage had migrated. Conclusions-There was no therapeutic benefit from the injection of rt-PA into subretinal haemorrhages without concomitant YAG, Zeiss, Germany) was focused just inside the edge of the bleb and the aiming beam was slightly defocused before discharging the laser. '6 Approximately 2-10 laser shots from 10 to 25 mJ were required to create a subretinal haemorrhage. Using this technique, subretinal haemorrhages in eight eyes in eight cats were formed. Indirect ophthalmoscopy and fundus photography were performed at selected time points. The sizes of the subretinal haemorrhages were measured from the fundus photographs in terms of optic disc diameters (one disc area of cat=0.9 mm). Using this technique, seven large subretinal haemorrhages A Figure 2 Gross photograph ofeye 14 days after tissue plasminogen activator was injected into a large subretinal haemorrhage i3 disc diameters. Note the large blood mass that has migrated inferiorly almost to the ora serrata (arrowhead). The letters correspond to the histopathological sections in Figure 3 .
(¢ 3 disc diameters, DD) ( Fig IA) and one small subretinal haemorrhage (6 2 DD) were created.
INJECTION OF rt-PA INTO THE SUBRETINAL HAEMORRHAGE
The recombinant tissue plasminogen activator (10 jg/ml) was infused into the subretinal space of 4 day old large subretinal haemorrhages in four eyes through a glass micropipette for 21/2-5 minutes at 20 jl/min for a total dose of 0.5-1.0 jig rt-PA. The volume of rt-PA injected was dependent on the size of the subretinal bleb needed to completely cover the subretinal haemorrhage.
TISSUE PROCESSING
For euthanasia, animals were premedicated with an intramuscular injection of ketamine hydrochloride (33 mg/kg), then given an intravenous injection ofpentobarbitone (85 mg/kg), followed by immediate enucleation. Eyes were incised at the pars plana and immersed in 2.5 % glutaraldehyde, 1.5% paraformaldehyde in 0.1 M sodium cacodylate buffer, pH 7 .4, at 4°C. After 15 minutes, the eye was hemisected and both the anterior and posterior portions were once again immersed in fixative for a period of 24 hours. The fixed posterior eye cups were dissected to isolate the area of interest by careful anatomical correlation with intraoperative video prints and postoperative photographs. The resulting tissue blocks were then bisected through the centre of each bleb, and each half was processed for either light or electron microscopy. 
Results

FIBRINOLYTIC THERAPY/CLINICAL RESULTS
Three large untreated subretinal haemorrhages were evaluated histopathologically at 2 and 4 weeks by light microscopy. These animals served as controls to confirmed previously published observations of outer retinal and RPE degeneration'6 (data not shown).
Four large subretinal haemorrhages (¢ 3 DD from four eyes) and one small subretinal haemorrhage (s 2 DD from one eye) were injected with 10 gg/ml of rt-PA into the subretinal space on the fourth day after the subretinal haemorrhage formation (Fig 1B) . In the large subretinal haemorrhages treated with rt-PA, the subretinal haemorrhages were noted to migrate inferiorly in a gravity dependent fashion beneath the non-tapetal retina within the first 48 hours after injection (Fig 2) . On funduscopic examination, the initial subretinal haemorrhage site had only a minimal veneer of subretinal haemorrhage and the retina appeared reattached. When rt-PA was injected into the small subretinal haemorrhage, there was no subretinal migration and the haemorrhage was completely resolved 3 days later.
FIBRINOLYTIC THERAPY/HISTOPATHOLOGICAL RESULTS Twenty one days after rt-PA was injected into the large subretinal haemorrhage areas (25 days total after subretinal haemorrhage formation), the retina at the initial subretinal haemorrhage site had severe outer retinal degeneration (Fig 3A) similar to that seen in the untreated large subretinal haemorrhages. Severe outer retinal degeneration was also present at the new site where the blood had migrated inferiorly (Fig 3B) . Minimal retinal degenerative changes were seen throughout the intervening retina, beneath which the subretinal blood had migrated (Fig 3C) .
Twenty one days after rt-PA was injected into the small subretinal haemorrhage, histological results were similar to those of untreated small subretinal haemorrhages as previously described'6 (data not shown).
Conclusion
Our study design was designed to mimic clinically relevant haemorrhages in a time frame commonly seen in clinical practice. We had hoped to devise a technique of treating subfoveal haemorrhages without surgical evacuation by simply injecting the fibrinolytic agent into the haemorrhage without the added mechanical manipulations required to aspirate the dissolved clot. Theoretically, this might hasten haemorrhage resorption and/or cause the blood to migrate out of the fovea into the inferior retina. In contrast with previous techniques,4 6 17 the use of the small micropipette reduced and perhaps eliminated the efflux of tPA injected into the subretinal haemorrhages from regressing back into the vitreous cavity. Accordingly, we were able to effect good clot dissolution with both low concentrations and small volume of tPA. Clot dissolution was evident within 20-30 minutes in all eyes examined in this study. Although, the rt-PA dissolved the organised blood coagulum and caused it to migrate in a gravity dependent manner to the inferior retina, outer retinal degenerative changes still occurred at the site of the initial subretinal haemorrhage. The intervening retina, under which the subretinal haemorrhage had migrated, showed only minimal changes similar to those seen after retinal reattachment after subretinal bleb formation."6 21 The retina over the site where the subretinal haemorrhage had migrated showed outer retinal degeneration that was equal in magnitude to those observed at the initial haemorrhage site. Thus, injecting rt-PA into large clotted subretinal haemorrhages without concomitant removal produced retinal degeneration at both the initial and secondary subretinal haemorrhage sites. Different observations were reported by Johnson et al'7 who used a different study design which did not mimic an expected clinical situation. In their study, tPA was injected into subretinal haemorrhages immediately after autologous blood was injected trans-sclerally into the subretinal space and then analysed 14 days later. In contrast with our study, no clot formation occurred when rt-PA was injected immediately after to injection of subretinal blood. Additionally, they found better preservation of the outer retinal structures in the region of the initial haemorrhage but extensive destruction to outer retinal structures in the inferior retina where the original non-clotted blood had migrated. More recently, Coll et at22 reported that intravitreal injection of rt-PA in the rabbit facilitated fibrinolysis of subretinal haemorrhages. They further reported that the electroretinograms were reduced in these animals, which suggested that retinal damage was not prevented by such intervention. However, because of the differences between the vasculature of the merangiotic rabbit model and the holangiotic cat model, and because no histopathological analysis was performed, a direct comparison of these results with ours is not possible.
There are several possible explanations for the degeneration that occurred at the initial subretinal haemorrhage site even though the blood had quickly migrated away from that site in our model. Because the original clot migrated away from the initial site soon after fibrinolysis had occurred, it seems unlikely that a theoretical metabolic barrier is the cause of outer retinal degeneration. Perhaps the nonmigrating residua of a lysed haemorrhage is toxic to the overlying retina. Toxicity might result from the release of fibrin degradation products and other toxins such as haemoglobin derived iron, methaemoglobin, or plasmin protease, resulting from fibrinolysis. Separate studies have shown that concomitant removal of lysed blood following rt-PA injection into 2-7-day-old subretinal haemorrhages results in preservation of the outer retinal architecture.""'5We do not find histopathological evidence to suggest that initial fibrinolysis is followed by fibrin reformation, resulting in mechanical damage to the outer retina and RPE as a result of gravity dependent migration. 
